Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
暂无分享,去创建一个
Aruna Chandran | A. Chandran | M. Santosham | Mathuram Santosham | S. Fitzwater | Sean Fitzwater | Anjie Zhen | A. Zhen
[1] D. Bernstein,et al. Efficacy of live, attenuated, human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial , 1999, The Lancet.
[2] S. Moore,et al. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. , 2002, The American journal of tropical medicine and hygiene.
[3] R. F. Ramig,et al. Pathogenesis of Intestinal and Systemic Rotavirus Infection , 2004, Journal of Virology.
[4] H. Szajewska,et al. Meta‐analysis: Lactobacillus GG for treating acute diarrhoea in children , 2007, Alimentary pharmacology & therapeutics.
[5] G. Ebrahim. Rotaviruses and rotavirus vaccines. , 2007, Journal of tropical pediatrics.
[6] M. Estes,et al. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. , 1993, The Journal of infectious diseases.
[7] M. Gracey. Diarrhoea in Australian Aborigines. , 2010, Australian journal of public health.
[8] A. Kapikian,et al. Rotavirus vaccines. , 1992, Biotechnology.
[9] R. Glass,et al. Molecular epidemiological profile of rotavirus in South Korea, July 2002 through June 2003: emergence of G4P[6] and G9P[8] strains. , 2005, The Journal of infectious diseases.
[10] R. Sack,et al. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. , 1991, The Journal of infectious diseases.
[11] H. Szajewska,et al. A multicentre study on behalf of the European Society of Paediatric Gastroenterology and Nutrition Working Group on Acute Diarrhoea. Early feeding in childhood gastroenteritis. , 1997, Journal of pediatric gastroenterology and nutrition.
[12] W Katherine Yih,et al. Real-Time Surveillance to Assess Risk of Intussusception and Other Adverse Events After Pentavalent, Bovine-Derived Rotavirus Vaccine , 2010, The Pediatric infectious disease journal.
[13] R. Glass,et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. , 1996, Pediatrics.
[14] K. Gottesdiener,et al. Concomitant Use of the Oral Pentavalent Human-Bovine Reassortant Rotavirus Vaccine and Oral Poliovirus Vaccine , 2008, The Pediatric infectious disease journal.
[15] A. W. Chung,et al. The effect of early oral feeding versus early oral starvation on the course of infantile diarrhea. , 1948, The Journal of pediatrics.
[16] G. Zissis,et al. FAILURE OF LIVE, ATTENUATED ORAL ROTAVIRUS VACCINE , 1986, The Lancet.
[17] Penelope H Dennehy. Rotavirus vaccines--an update. , 2007, Vaccine.
[18] R. Glass,et al. Rotavirus and Severe Childhood Diarrhea , 2006, Emerging infectious diseases.
[19] T. Vesikari,et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study , 2007, The Lancet.
[20] Penny M Heaton,et al. Efficacy of Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine Based on Breastfeeding Frequency , 2008, The Pediatric infectious disease journal.
[21] Roger I Glass,et al. Global impact of rotavirus vaccines , 2010, Expert review of vaccines.
[22] H. Bernstein,et al. Update on universal childhood immunizations , 2008, Current opinion in pediatrics.
[23] Manish M Patel,et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. , 2010, The Journal of infectious diseases.
[24] C. Sánchez,et al. Use of racecadotril as outpatient treatment for acute gastroenteritis: a prospective, randomized, parallel study. , 2009, The Journal of pediatrics.
[25] N. Alam,et al. Treatment of Infectious Diarrhea in Children , 2003, Paediatric drugs.
[26] P. Krasilnikoff,et al. Rapid versus Gradual Refeeding in Acute Gastroenteritis in Childhood: Energy Intake and Weight Gain , 1989, Journal of pediatric gastroenterology and nutrition.
[27] Robert J. Glass,et al. Effectiveness of the Pentavalent Rotavirus Vaccine in Preventing Gastroenteritis in the United States , 2010, Pediatrics.
[28] G. Barnes,et al. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] L. Shulman,et al. Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: A case-control study , 2010, Human vaccines.
[30] P. Dennehy,et al. Coadministration of RIX4414 Oral Human Rotavirus Vaccine Does Not Impact the Immune Response to Antigens Contained in Routine Infant Vaccines in the United States , 2008, Pediatrics.
[31] J. Gray,et al. A mathematical model of the indirect effects of rotavirus vaccination , 2009, Epidemiology and Infection.
[32] R. Black,et al. Effectiveness of Zinc Supplementation Plus Oral Rehydration Salts Compared With Oral Rehydration Salts Alone as a Treatment for Acute Diarrhea in a Primary Care Setting: A Cluster Randomized Trial , 2008, Pediatrics.
[33] Miguel O'Ryan,et al. Update on Rotarix™: an oral human rotavirus vaccine , 2009, Expert review of vaccines.
[34] K. Taniguchi,et al. PROTECTIVE EFFECT OF NATURALLY ACQUIRED HOMOTYPIC AND HETEROTYPIC ROTAVIRUS ANTIBODIES , 1986, The Lancet.
[35] Organización Mundial de la Salud. Clinical management of acute diarrhoea , 2004 .
[36] G. Zissis,et al. PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINE , 1984, The Lancet.
[37] D. Sack,et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. , 2009, Vaccine.
[38] R. Glass,et al. Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam. , 2009, Vaccine.
[39] U. Parashar,et al. Acute, infectious diarrhea among children in developing countries , 2004, Seminars in Pediatric Infectious Diseases.
[40] J. Matthijnssens,et al. Rotavirus disease and vaccination: impact on genotype diversity. , 2009, Future microbiology.
[41] Robert E Black,et al. WHO estimates of the causes of death in children , 2005, The Lancet.
[42] R. Glass,et al. Rotavirus infection in infants as protection against subsequent infections. , 1996, The New England journal of medicine.
[43] S. Madhi,et al. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. , 2009, The Journal of infectious diseases.
[44] N. Patel,et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. , 2010, The New England journal of medicine.
[45] D. Salisbury,et al. Immunization campaigns in the UK. , 2006, Current Topics in Microbiology and Immunology.
[46] G. Beards,et al. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. , 1990, American journal of diseases of children.
[47] R. Glass,et al. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. , 1999, Vaccine.
[48] K. Dolan,et al. Diverse serologic response to rotavirus infection of infants in a single epidemic. , 1985, Pediatric infectious disease.
[49] M. Estes,et al. Rotaviruses: from pathogenesis to vaccination. , 2009, Gastroenterology.
[50] D. Bernstein. Rotavirus Overview , 2009, The Pediatric infectious disease journal.
[51] K. Mølbak,et al. Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa. , 2002, The Journal of infectious diseases.
[52] Y. V. van Duynhoven,et al. Risk Factors for Norovirus, Sapporo-like Virus, and Group A Rotavirus Gastroenteritis , 2003, Emerging infectious diseases.
[53] C. Sanderson,et al. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data , 2009, The Lancet.
[54] M. Pichichero,et al. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. , 1996, The Journal of infectious diseases.
[55] J. Aranda,et al. A Meta-analysis of the Effects of Oral Zinc in the Treatment of Acute and Persistent Diarrhea , 2008, Pediatrics.
[56] U. Intusoma,et al. Epidemiology, clinical presentations and burden of rotavirus diarrhea in children under five seen at Ramathibodi Hospital, Thailand. , 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[57] F. Shafi,et al. TRENDS IN HOSPITALIZATIONS FROM ALL-CAUSE GASTROENTERITIS IN CHILDREN YOUNGER THAN 5 YEARS OF AGE IN BRAZIL BEFORE AND AFTER HUMAN ROTAVIRUS VACCINE INTRODUCTION, 1998–2007 , 2010, The Pediatric infectious disease journal.
[58] Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations. , 2009, Releve epidemiologique hebdomadaire.
[59] R. Sack,et al. Oral rehydration therapy and dietary therapy for acute childhood diarrhea. , 1987, Pediatrics in review.
[60] S. Taneja,et al. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. , 2009, The Journal of infectious diseases.
[61] R. Glass,et al. Global mortality associated with rotavirus disease among children in 2004. , 2009, The Journal of infectious diseases.
[62] R. Glass,et al. Safety and Efficacy of High-dose Rhesus-Human Reassortant Rotavirus Vaccines-Report of the National Multicenter Trial , 1996, Pediatrics.
[63] J. Stockman,et al. Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine , 2007 .
[64] M. Claeson,et al. Management of acute diarrhea in children: lessons learned , 1993, The Pediatric infectious disease journal.
[65] R. Ward,et al. Comparative Evaluation of Safety and Immunogenicity of Two Dosages of an Oral Live Attenuated Human Rotavirus Vaccine , 2005, The Pediatric infectious disease journal.
[66] R. Yolken,et al. Role of soy-based, lactose-free formula during treatment of acute diarrhea. , 1985, Pediatrics.
[67] C. Teran,et al. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[68] J. L. Adams,et al. On diarrhoea. , 1946, The New Zealand medical journal.
[69] Y. Lau,et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. , 2009, Vaccine.
[70] C. Surawicz,et al. Loperamide use for acute infectious diarrhea in children: safe and sound? , 2008, Gastroenterology.
[71] Robert E Black,et al. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial , 2002, BMJ : British Medical Journal.
[72] P. Garner,et al. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. , 2002, The Cochrane database of systematic reviews.
[73] J. Matthijnssens,et al. Zoonotic aspects of rotaviruses. , 2010, Veterinary microbiology.
[74] Manish M Patel,et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. , 2009, JAMA.
[75] M. Claeson,et al. Global progress in the control of diarrheal diseases. , 1990, The Pediatric infectious disease journal.
[76] S. Guandalini. Probiotics for Children With Diarrhea: An Update , 2008, Journal of clinical gastroenterology.
[77] Mei-Hwei Chang,et al. Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.
[78] Manish M Patel,et al. Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United States , 2010, Pediatrics.
[79] Y. Hoshino,et al. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine , 2005, Reviews in medical virology.
[80] Manish M Patel,et al. Reduction in rotavirus after vaccine introduction--United States, 2000-2009. , 2009, MMWR. Morbidity and mortality weekly report.
[81] Manish M Patel,et al. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. , 2009, The Journal of infectious diseases.
[82] H. Szajewska,et al. Meta‐analysis: zinc supplementation for acute gastroenteritis in children , 2008, Alimentary pharmacology & therapeutics.
[83] V. Gouvea,et al. Changing distribution of human rotavirus serotypes during two epidemic outbreaks of gastroenteritis in Campinas, São Paulo, Brazil, 2003-2004: detection of G6 strains. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[84] L. Ronfani,et al. Oral zinc for treating diarrhoea in children. , 2012, The Cochrane database of systematic reviews.
[85] S. Moore,et al. Early Childhood Diarrhea Predicts Impaired School Performance , 2006, The Pediatric infectious disease journal.
[86] R. Guerrant,et al. Updating the DALYs for diarrhoeal disease. , 2002, Trends in parasitology.
[87] Toyoko Nakagomi,et al. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. , 2009, Gastroenterology.
[88] C. Mathers,et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis , 2010, The Lancet.
[89] D. Bernstein,et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. , 1998, Vaccine.
[90] A. Kapikian,et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. , 1997, The New England journal of medicine.
[91] N. Pal,et al. A randomized controlled trial to evaluate the efficacy of lactobacillus GG in infantile diarrhea. , 2009, The Journal of pediatrics.
[92] Y. Paul. Oral polio vaccines and their role in polio eradication in India , 2009, Expert review of vaccines.
[93] T. Vesikari,et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. , 2004, Vaccine.
[94] G. Beards,et al. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. , 1985, The Journal of pediatrics.
[95] Ming Wang,et al. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. , 2007, Vaccine.
[96] G. Koch,et al. Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[97] Penny M Heaton,et al. Safety and Efficacy of the Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine in Healthy Premature Infants , 2007, The Pediatric infectious disease journal.
[98] A. Curns,et al. Secular Variation in United States Rotavirus Disease Rates and Serotypes: Implications for Assessing the Rotavirus Vaccination Program , 2009, The Pediatric infectious disease journal.
[99] D. Bernstein. Live attenuated human rotavirus vaccine, Rotarix. , 2006, Seminars in pediatric infectious diseases.
[100] B. Schwartz,et al. Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.
[101] A. Cheng,et al. Infectious diarrhea in developed and developing countries. , 2005, Journal of clinical gastroenterology.
[102] G. Barnes,et al. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. , 1983, The New England journal of medicine.
[103] M. Santoro,et al. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial , 2006, The Lancet.
[104] D. Bernstein,et al. Clinical presentations of rotavirus infection among hospitalized children , 2002, The Pediatric infectious disease journal.
[105] J. Heyse,et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.
[106] R. Yolken,et al. Detection of rotavirus in respiratory secretions of children with pneumonia. , 1983, The Journal of pediatrics.
[107] R. Glass,et al. Development of candidate rotavirus vaccines derived from neonatal strains in India. , 2005, The Journal of infectious diseases.
[108] R. Holman,et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. , 1996, The Journal of infectious diseases.
[109] A. Steele,et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. , 2010, Vaccine.
[110] M. Ng,et al. Rotavirus infection of the oropharynx and respiratory tract in young children , 1991, Journal of medical virology.
[111] Li An. Observation of Immunization Effect and Reverse Reaction of Rotavirus Vaccine , 2002 .
[112] L. Cuevas,et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine , 2008, Archives of Virology.
[113] A. Chandran,et al. RotaTeq™: a three-dose oral pentavalent reassortant rotavirus vaccine , 2008, Expert review of vaccines.
[114] R. Glass,et al. The management of acute diarrhea in children: oral rehydration, maintenance, and nutritional therapy. Centers for Disease Control and Prevention. , 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[115] A. Kapikian,et al. Rotavirus vaccines: an overview , 1996, Clinical microbiology reviews.
[116] Roger I Glass,et al. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[117] T. Vesikari,et al. Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants , 2004, The Pediatric infectious disease journal.
[118] R. Glass,et al. Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. , 2006, Vaccine.
[119] Y. Qian,et al. Hospital-Based Surveillance of Rotavirus Diarrhea in the People's Republic of China, August 2003-July 2007. , 2009, The Journal of infectious diseases.
[120] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.